Finance Home - My Yahoo - Yahoo! - Help

Wednesday, February 10, 2010, 7:15AM ET - U.S. Markets open in 2 hours and 15 minutes. Dow  1.52% Nasdaq  0.00%

Chelsea Therapeutics International Ltd. (CHTP)

On Feb 9: 2.53   0.00 (0.00%)

MORE ON CHTP

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Feb 9, 2010 • CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib EDGAR Online (Tue 1:29pm) • Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Program GlobeNewswire (Tue 7:30am) Fri, Feb 5, 2010 • How the Brokers Stack Up at Barrons.com (Fri, Feb 5) Wed, Feb 3, 2010 • Chelsea Therapeutics to Present at 12th Annual BIO CEO & Investor Conference GlobeNewswire (Wed, Feb 3) Mon, Feb 1, 2010 • [video] Trading Smallcap Biotech at TheStreet.com (Mon, Feb 1) Thu, Jan 21, 2010 • Insider Sells $8.3M Worth of Complete Production Svs TheStreet.com (Thu, Jan 21) Tue, Jan 19, 2010 • GenVec, Allied Defense: Early Volume Plays at TheStreet.com (Tue, Jan 19) Wed, Dec 16, 2009 • CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib EDGAR Online (Wed, Dec 16) • StockPreacher Initiates Independent Research Coverage for Chelsea Therapeutics International Inc. GlobeNewswire (Wed, Dec 16) Tue, Dec 15, 2009 • Chelsea Therapeutics Granted Approval to Change the Primary Endpoint and Increase Enrollment in Droxidopa Pivotal Study 301 GlobeNewswire (Tue, Dec 15) Mon, Dec 14, 2009 • Chelsea Therapeutics Reports Subgroup Analysis of 44 Parkinson's Patients in Study 302 Shows Highly Statistically Significant Benefits of Droxidopa Therapy GlobeNewswire (Mon, Dec 14) Thu, Nov 12, 2009 • Results From Chelsea Therapeutics' Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Presented at 20th Annual International Symposium on the Autonomic Nervous System GlobeNewswire (Thu, Nov 12) Fri, Nov 6, 2009 • CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Financials EDGAR Online Financials (Fri, Nov 6) • Biotech Stock Mailbag: Poniard Predictions at TheStreet.com (Fri, Nov 6) Tue, Nov 3, 2009 • YRC Worldwide: Midday Volume Movers at TheStreet.com (Tue, Nov 3) • Chelsea Just Got Riskier: BioBuzz at TheStreet.com (Tue, Nov 3) • The Long Trade in Chelsea Becomes Riskier: BioBuzz at TheStreet.com (Tue, Nov 3) Mon, Nov 2, 2009 • CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon, Nov 2) • Chelsea Therapeutics Reports Third Quarter 2009 Results GlobeNewswire (Mon, Nov 2) • Chelsea Therapeutics Appoints Dr. William D. Schwieterman Chief Medical Officer GlobeNewswire (Mon, Nov 2) Older Headlines - Download Recent Headlines View headlines from: Mon, Nov 2, 2009Mon, Oct 26, 2009Mon, Oct 19, 2009Mon, Oct 12, 2009Mon, Oct 5, 2009Mon, Sep 28, 2009Mon, Sep 21, 2009Mon, Sep 14, 2009Mon, Sep 7, 2009Mon, Aug 31, 2009 Add CHTP News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage